CALS Patient Activated Learning System (PALS)
Launched by CORNELL UNIVERSITY · Dec 24, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Participants will view, in randomized order, PALS or WebMD content on hypertension and on high cholesterol. This study will test knowledge uptake across topics as well as attitudes toward and trust in the information and information providers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient ≥ 18 years of age.
- • Self-reported hypertension diagnosis.
- • English speaking
- • Passing the cognition screener
- • Able to read in English
- • Patient at designated recruitment clinics
- Exclusion Criteria:
- • Non-English speakers
- • Not having self-identified as having hypertension
- • Inability to read in English
- • Being younger than 18
- • Not passing the screener
- • Not being a patient on the participating clinics
Trial Officials
Neil Lewis, PhD
Principal Investigator
Cornell University
About Cornell University
Cornell University is a prestigious Ivy League institution renowned for its commitment to academic excellence and innovative research. As a clinical trial sponsor, Cornell leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university fosters collaboration among leading researchers, clinicians, and students, aiming to translate scientific discoveries into effective therapies. Cornell's rigorous adherence to ethical standards and regulatory compliance ensures the integrity and safety of its clinical trials, contributing to the advancement of healthcare and the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
